Phase 3 Overweight or Obesity Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
OsteoarthritisOverweight or Obesity
Eli Lilly and Company900 enrolled154 locationsNCT07353931
Recruiting
Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
HypertensionOverweight or Obesity
Eli Lilly and Company487 enrolled99 locationsNCT06948435
Recruiting
Phase 3
Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
Overweight or Obesity
Gan & Lee Pharmaceuticals.500 enrolled2 locationsNCT07292441
Recruiting
Phase 3
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Atrial FibrillationOverweight or Obesity
University of Chicago200 enrolled2 locationsNCT06499857
Recruiting
Phase 3
A Study of BGM0504 Injection in Participants with Obesity or Overweight
Overweight or Obesity
BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.620 enrolled1 locationNCT06704581